Madrigal Pharmaceuticals Stock Price on November 20, 2024

MDGL Stock  USD 310.87  2.43  0.79%   
Below is the normalized historical share price chart for Madrigal Pharmaceuticals extending back to February 06, 2007. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Madrigal Pharmaceuticals stands at 310.87, as last reported on the 23rd of December, with the highest price reaching 311.18 and the lowest price hitting 302.16 during the day.
IPO Date
6th of February 2007
200 Day MA
256.9903
50 Day MA
288.8802
Beta
(0.47)
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Madrigal Stock, it is important to understand the factors that can impact its price. Madrigal Pharmaceuticals appears to be very steady, given 3 months investment horizon. Madrigal Pharmaceuticals has Sharpe Ratio of 0.13, which conveys that the firm had a 0.13% return per unit of risk over the last 3 months. By analyzing Madrigal Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.57% is justified by implied risk. Please exercise Madrigal Pharmaceuticals' Risk Adjusted Performance of 0.0882, mean deviation of 2.71, and Downside Deviation of 2.46 to check out if our risk estimates are consistent with your expectations.
  
At this time, Madrigal Pharmaceuticals' Common Stock is quite stable compared to the past year. Stock Based Compensation is expected to rise to about 52.2 M this year, although the value of Sale Purchase Of Stock will most likely fall to about 256.7 K. . At this time, Madrigal Pharmaceuticals' Price To Sales Ratio is quite stable compared to the past year. Price Book Value Ratio is expected to rise to 11.20 this year, although the value of Price Earnings To Growth Ratio is projected to rise to (0.76). Madrigal Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1264

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsMDGL
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 4.55
  actual daily
40
60% of assets are more volatile

Expected Return

 0.57
  actual daily
11
89% of assets have higher returns

Risk-Adjusted Return

 0.13
  actual daily
9
91% of assets perform better
Based on monthly moving average Madrigal Pharmaceuticals is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Madrigal Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book
8.6638
Enterprise Value Ebitda
(8.32)
Price Sales
87.5789
Shares Float
10.7 M
Wall Street Target Price
373

Related Headline

Day One Headline on 20th of November 2024

Dr. Blackmans departure planned for end of 2024 Companys search for a new Head of RD is ongoing BRISBANE, Calif., Nov. 20, 2024 GLOBE...

Madrigal Pharmaceuticals Valuation on November 20, 2024

It is possible to determine the worth of Madrigal Pharmaceuticals on a given historical date. On November 20, 2024 Madrigal was worth 315.75 at the beginning of the trading date compared to the closed value of 317.09. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Madrigal Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Madrigal Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Madrigal Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Madrigal Pharmaceuticals' related companies.
 Open High Low Close Volume
  305.00    320.89    304.35    314.17    380,877  
11/20/2024
  315.75    323.99    310.83    317.09    326,795  
  318.42    329.93    315.15    329.24    423,616  
Backtest Madrigal Pharmaceuticals  |  Madrigal Pharmaceuticals History  |  Madrigal Pharmaceuticals Valuation   PreviousNext  
Open Value
315.75
302.11
Downside
317.09
Closing Value
329.39
Upside

Madrigal Pharmaceuticals Trading Date Momentum on November 20, 2024

On November 21 2024 Madrigal Pharmaceuticals was traded for  329.24  at the closing time. The top price for the day was 329.93  and the lowest listed price was  315.15 . The trading volume for the day was 423.6 K. The trading history from November 21, 2024 was a factor to the next trading day price upswing. The trading delta at closing time against the next closing price was 3.83% . The trading delta at closing time against the current closing price is 2.61% .

Madrigal Pharmaceuticals Fundamentals Correlations and Trends

By evaluating Madrigal Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Madrigal Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Madrigal financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Madrigal Pharmaceuticals Stock history

Madrigal Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Madrigal is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Madrigal Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Madrigal Pharmaceuticals stock prices may prove useful in developing a viable investing in Madrigal Pharmaceuticals
Last ReportedProjected for Next Year
Common Stock Shares Outstanding18.7 M19.6 M
Net Loss-265.8 M-252.5 M

Madrigal Pharmaceuticals Quarterly Net Working Capital

885.82 Million

Madrigal Pharmaceuticals Stock Technical Analysis

Madrigal Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Madrigal Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Madrigal Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Madrigal Pharmaceuticals Period Price Range

Low
December 23, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Madrigal Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Madrigal Pharmaceuticals December 23, 2024 Market Strength

Market strength indicators help investors to evaluate how Madrigal Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Madrigal Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Madrigal Pharmaceuticals stock market strength indicators, traders can identify Madrigal Pharmaceuticals entry and exit signals to maximize returns

Madrigal Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Madrigal Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Madrigal Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Madrigal to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Madrigal Pharmaceuticals is a strong investment it is important to analyze Madrigal Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Madrigal Pharmaceuticals' future performance. For an informed investment choice regarding Madrigal Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Madrigal Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
For more information on how to buy Madrigal Stock please use our How to buy in Madrigal Stock guide.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Madrigal Pharmaceuticals. If investors know Madrigal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Madrigal Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(25.04)
Revenue Per Share
3.705
Return On Assets
(0.52)
Return On Equity
(1.30)
The market value of Madrigal Pharmaceuticals is measured differently than its book value, which is the value of Madrigal that is recorded on the company's balance sheet. Investors also form their own opinion of Madrigal Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Madrigal Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Madrigal Pharmaceuticals' market value can be influenced by many factors that don't directly affect Madrigal Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Madrigal Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Madrigal Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Madrigal Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.